What is Bicara Therapeutics's return on invested capital?

Bicara Therapeutics (BCAX) reported return on invested capital of -100.6% in Q4 2025.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Bicara Therapeutics BCAX Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

42%+16.6pp

AmgenAMGN

14.1%+4.0pp

ArriVent BioPharma, Inc.AVBP

-75.6%-28.0pp

ImmunomeIMNM

-746.6%+212pp

Arcus BiosciencesRCUS

-95.3%+1.8pp

Syndax PharmaceuticalsSNDX

-67.9%-12.9pp

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Calculated from Bicara Therapeutics’s reported figures.

nopat/invested capital=-100.6%

Based on trailing twelve months.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's return on invested capital?: Bicara Therapeutics (BCAX) reported return on invested capital of -100.6% in Q4 2025.
What does return on invested capital mean?: Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.